Zio AT® device (A100A1001)

FDA 510(k) K240029 · iRhythm Technologies, Inc.

Substantially Equivalent

510(k) numberK240029

Submission

Device name
Zio AT® device (A100A1001)
Applicant
iRhythm Technologies, Inc.
San Francisco, CA, US
Received
January 4, 2024
Decision date
October 21, 2024
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
QYX – Outpatient Cardiac Telemetry
Device class
Class II (moderate risk)
Regulation
21 CFR 870.1025
Specialty
Cardiovascular

Devices are intended to continuously record and analyze electrocardiograms for automatic detection and recording of cardiac electrical activity in an outpatient setting. Detected, notifiable events are transmitted to the prescribing clinician during the monitoring period by a 24/7 attended analysis center after review by a qualified individual. Devices may allow remote access and display of…

Other 510(k)s with product code QYX

510(k)DeviceApplicantDecision
K250793RhythmStar System (SL)QYX · Traditional RhythMedix, LLC04/21/2026SE
K241179Rhythm Express Remote Cardiac Monitoring System (RX-1 mini)QYX · Traditional VivaQuant, Inc.07/11/2025SE
K240653SmartCardia 7L Platform (MCT)QYX · Traditional Smartcardia SA10/31/2024SE
K233584RhythmStar SystemQYX · Traditional RhythMedix, LLC07/08/2024SE
K162956Nowcardio SystemQYX · Abbreviated Contex International Technologies (Canada), Inc.09/22/2017SE
K170565LifeWatch Mobile Cardiac Telemetry 3 Lead LifeWatch MCT 3LQYX · Traditional Lifewatch Services, Inc.08/01/2017SE
K163512Zio AT ECG Monitoring SystemQYX · Traditional iRhythm Technologies, Inc.06/02/2017SE
K160064MoMe Kardia Wireless Ambulatory ECG Monitoring and Detection SystemQYX · Abbreviated Infobionic, Inc.03/11/2016SE
K133753Mome ECG Continuous Detection and Arrhythmia DetectorQYX · Traditional Infobionic, Inc.09/19/2014SE
K133701Nuvant MCT SystemQYX · Special Corventis, Inc.02/06/2014SE

More from Corventis, Inc.

510(k)DeviceDecision
K252859ZEUS Platform (FG0501US)DQK · Traditional 05/29/2026SE
K243650Zio® monitor (DFG0001)DSH · Traditional 08/15/2025SE
K240177Zio AT® device (A100A1001)DSI · Traditional 10/30/2024SE
K222389ZEUS SystemDQK · Traditional 02/15/2023SE
K213409ZEUS System (Zio Watch)DQK · Traditional 07/19/2022SE
K202527Zio ECG Utilization Software (ZEUS) SystemDQK · Traditional 05/21/2021SE
K202359Zio MonitorDSH · Traditional 05/21/2021SE
K190593Zio XT ECG Monitoring System, Zio AT ECG Monitoring SystemDQK · Traditional 08/23/2019SE
K181502Zio AT ECG Monitoring System, ZEUS SystemDQK · Traditional 08/29/2018SE
K163512Zio AT ECG Monitoring SystemQYX · Traditional 06/02/2017SE

Questions and answers

When was Zio AT® device (A100A1001) cleared by the FDA?

Zio AT® device (A100A1001) (K240029) received a 510(k) decision of Substantially Equivalent on October 21, 2024, 291 days after the submission was received.

What is the product code of K240029?

The FDA product code is QYX – Outpatient Cardiac Telemetry, a Class II (moderate risk) device regulated under 21 CFR 870.1025.